Today: 16 May 2026
Nio March Deliveries Jump 136% as EV Maker Beats Q1 Goal, Firefly Posts Strong Month
1 April 2026
1 min read

Nio March Deliveries Jump 136% as EV Maker Beats Q1 Goal, Firefly Posts Strong Month

SHANGHAI, April 1, 2026, 20:04 CST

Nio reported March deliveries of 35,486 vehicles, a 136% jump from the same month last year, with first-quarter numbers reaching 83,465—just over its 80,000 to 83,000 vehicle guidance. For March, the breakdown: 22,490 from the flagship Nio brand, 6,877 Onvo units, and 6,119 Firefly models. Total deliveries now stand at 1,081,057.

These figures arrive just weeks after Nio announced its maiden quarterly adjusted operating profit—a metric that excludes certain standard accounting items—at a critical juncture, with the automaker gearing up for an April launch push aimed at sustaining demand. Earlier in the day, before Nio published its latest delivery update, the company’s Hong Kong shares jumped roughly 10%. Investors seemed confident: expectations were high for robust March deliveries, and anticipation builds around fresh models.

Nio’s core brand carried the momentum. According to CnEVPost, which referenced company figures, the all-new ES8 recorded 16,255 March deliveries. Nio itself reported the ES8 reached its 80,000th delivery as of March 20, and has held the top spot in China’s large-SUV sector three months running.

Firefly sharpened its presence, too. Sales jumped to 6,119 units in March—twice February’s volume—marking its second-best monthly tally ever. On March 28, the compact EV brand surpassed 50,000 total deliveries. Then, last week, Firefly rolled out its right-hand-drive model in Thailand, pricing it at 799,000 baht.

Nio is counting on that niche label to drive international expansion. Earlier this year, William Li called Firefly “our pioneering brand for global market entry,” and at the Bangkok motor show, brand chief Daniel Jin said the marque is aiming for launches in 20 to 30 countries this year. EV

Li Auto put up 41,053 deliveries in March, while Leapmotor posted 50,029 and Xpeng came in at 27,415. Nio edged past Xpeng for the month but couldn’t catch up to Leapmotor or Li Auto.

The company’s ramping up for a packed launch calendar. April 2 will see refreshed versions of the ES6, EC6, ET5, and ET5 Touring. A tech event focused on the ES9 comes up a week later, on April 9. Onvo’s L80 large SUV is slated to hit the market in May.

Keeping up that momentum won’t be easy. Firefly accounted for under 20% of group deliveries in March, and its first-quarter number—11,583—is nowhere near the pace required for 100,000 vehicles by 2026. Last week, Jin called brand awareness “our biggest roadblock.” The landscape isn’t any smoother outside the company, either: BYD saw sales drop for a seventh straight month in March, squeezed by price wars in China’s EV space. NIO Inc.

Nio reported a fourth-quarter adjusted operating profit of 1.25 billion yuan in March, crediting cost reductions, higher deliveries, and an improved sales mix for the gain. New delivery figures out Wednesday seem to reinforce that upturn. Now, future growth will hinge on the success of upcoming models and the company’s push abroad.

Stock Market Today

  • W. R. Berkley (WRB) Shows 45.9% Undervaluation Despite Recent Price Stability
    May 15, 2026, 7:55 PM EDT. W. R. Berkley (WRB) stock has shown limited movement recently with a 1.2% gain over 7 days and a 4.2% decline year-to-date. Analysts use valuation methods like Excess Returns, which estimates intrinsic value by calculating profits above shareholder required returns. With an intrinsic value estimate of $122.79 against a current price near $66.45, the stock appears 45.9% undervalued. The insurer's steady underwriting profile and capital discipline contrast with sector concerns on insurance pricing and interest rate sensitivity. WRB currently scores 2 out of 6 on valuation metrics, highlighting potential but raising caution.

Latest articles

Accuray inks 10-year cancer tech agreement, shares in focus

Accuray inks 10-year cancer tech agreement, shares in focus

16 May 2026
Accuray and the University of Wisconsin School of Medicine and Public Health signed a 10-year research agreement focused on Accuray’s Stellar adaptive radiotherapy platform. The announcement came after market close, with Accuray shares ending down 5.2% at $0.27. The deal follows Accuray’s recent withdrawal of fiscal 2026 guidance and ongoing financial pressures.
Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

16 May 2026
Origin Materials asked shareholders to approve a plan to liquidate and dissolve the company, estimating an initial payout of $0.61 to $3.54 per share depending on asset sales and claims. Shares rose 15% to $1.43 after the filing. The company reported a 91% drop in first-quarter revenue and warned it may not survive without the wind-down. Origin cut 59% of its workforce and CEO John Bissell stepped down May 1.
NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

16 May 2026
NextNRG reported first-quarter revenue of $21.1 million, up 29% from a year earlier, but its net loss widened to $10.8 million. Cash fell to $208,048 at quarter-end, and management warned it needs immediate capital to continue operations. Shares closed at $0.2804 on Nasdaq, down nearly 6%. Total liabilities reached $34.3 million, with a stockholders’ deficit of $22 million.
HCW Biologics jumps 262% after Trimmune deal, Q1 profit, Nasdaq risk update

HCW Biologics jumps 262% after Trimmune deal, Q1 profit, Nasdaq risk update

16 May 2026
HCW Biologics shares jumped 262% to $1.22 Friday after the company posted a $3.47 million first-quarter profit, driven by a $6.5 million licensing deal with Beijing Trimmune Biotech. The company faces a possible Nasdaq delisting and will ask shareholders to approve a reverse stock split on June 15. HCW plans to report early Phase 1 data for its alopecia drug in the first half of 2026.
Fidelity to Close Eight Canada Funds as Freedom 2045, 2015 Beat Benchmarks in Q4
Previous Story

Fidelity to Close Eight Canada Funds as Freedom 2045, 2015 Beat Benchmarks in Q4

Stock Market Closed on Good Friday 2026? NYSE, Nasdaq Shut as Jobs Report Lands
Next Story

Stock Market Closed on Good Friday 2026? NYSE, Nasdaq Shut as Jobs Report Lands

Go toTop